top of page

Advances in Pulmonary Hypertension: Quality of Life

Jul 10, 2022
1 min read

About Advances in Pulmonary Hypertension magazine:


Advances in Pulmonary Hypertension: Official Journal of the Pulmonary Hypertension Association (PHA) is a quarterly publication directed by an editorial board of renowned pulmonary hypertension (PH) experts with oversight by PHA's Scientific Leadership Council.


Its mission is to assist physicians in their clinical decision-making by informing them of important trends affecting their practice and providing an analysis of the impact of new findings in peer-reviewed publications. Issue themes are independently selected by the Editorial Board after an analysis of newly released data and practice gaps. A guest editor invites thought leaders in the selected topic area to author reviews of these timely subject. Each article is finally reviewed and approved by members of the Editorial Board.


 
 
 

Recent Posts

Animal research shows miR-224 contributes to PAH

A small molecule called microRNA-224-5p (miR-224) appears to play an important role in the changes to the lung blood vessels that occur in pulmonary arterial hypertension (PAH). Researchers found that

 
 
 
Dual PH therapy before BPA lowers complications

Researchers found that pre-treating pulmonary hypertension (PH) patients with dual therapy before they underwent balloon pulmonary angioplasty was associated with lower complications and better clinic

 
 
 

Comments


PHA Canada

408 - 55 Water Street

Office 8928

Vancouver, BC, V6B 1A1

Email: info@phacanada.ca

Phone: 604-682-1036

Toll Free: 1-877-774-2226

Charitable Registration # 872050224RR0001

  • Instagram
  • Facebook
  • X
  • LinkedIn
  • Youtube

Copyright 2025 PHA CANADA, ALL RIGHTS RESERVED   |   Website created by Creativibe

bottom of page